Retrospective study of spectrum of ovarian tumours in a tertiary care setup

Authors

  • Vimala Chelladurai Department of Pathology, Saveetha Medical College and hospital,Saveetha University,Thandalam,Chennai(India)
  • Vimal Chander Department of Pathology, Saveetha Medical College and hospital,Saveetha University,Thandalam,Chennai(India)
  • Chitra Srinivasan Department of Pathology, Saveetha Medical College and hospital,Saveetha University,Thandalam,Chennai(India)

Keywords:

Ovarian cancer, Surface epithelial tumours, Serous cystadenoma, Germ cell tumours, Sex cord Stromal tumours

Abstract

Background: Ovarian cancer accounts for 3% of all cancers in women. 80% of the ovarian tumors are benign, occurring in the age group of 20 to 45 years whereas malignant tumors are common in elderly women, between 45 to 65 years. Ovarian cancer is the sixth most common cancer (age standardized incidence rate of 6.6 /100,000) and the seventh leading cause of cancer deaths (age standardized mortality rate of 4/100,000) among women worldwide

Methods: All ovarian tumors diagnosed over a period of 39 months from January 2014 to March 2017 in the Department of Pathology, Saveetha Medical College, Thandalam, Chennai, Tamil Nadu were included in this study

Result: Out of a total of 61 ovarian tumor specimens, 53 were surface epithelial tumors and 4 were germ cell tumors and 4 were sex cord stromal tumors. Out of 61 cases, there were 52 benign, 8 malignant and 1 borderline tumors.  Most common histological type was surface epithelial tumors. Most common benign tumor was serous cystadenoma (42 cases) and the malignant tumor was serous cystadenocarcinoma (4 cases). 

Conclusion: The most common ovarian tumor was surface epithelial tumors and the most common benign tumor among surface epithelial tumor was serous cystadenoma. The commonest malignant tumor was surface epithelial tumor which was common among patients who are above 60 years of age.

DOI: 10.21276/APALM.1672

Author Biographies

Vimala Chelladurai, Department of Pathology, Saveetha Medical College and hospital,Saveetha University,Thandalam,Chennai(India)

Final year M.D Pathology

Saveetha Medical College

Vimal Chander, Department of Pathology, Saveetha Medical College and hospital,Saveetha University,Thandalam,Chennai(India)

Associate Professor

Department of Pathology

Saveetha Medical College

Saveetha University

Chitra Srinivasan, Department of Pathology, Saveetha Medical College and hospital,Saveetha University,Thandalam,Chennai(India)

HOD and Professor

Department of Pathology

Saveetha Medical College

Saveetha University

References

1.Kumar, V., & Robbins, S. L. 1. (2007). Robbins basic pathology (9th ed.).Chapter 22;The Female Genital Tract;1022

2.Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin.2005;55(2):74–108

3.Consolidated Report of the Population Based Cancer Registries 2001-2004: National Cancer Registry Programme. Bangalore: Indian Council of Medical Research; 2006.

4. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin.2006;56(2):106–30
5. Changing Trends in Incidence of Ovarian Cancer - the Indian Scenario. Asian Pacific Journal of Cancer Prevention, 2009; 10(6): 1025-1030.

6.Shaikh NA, Hashmi F, Samoo RP. Pattern of ovarian tumors: report of 15 years experience at Liaquat University Jamshoro. J LiaquatUni Med Health Sci 2007;6:13-5.

7.Gupta N, Bisht D, Agarwal AK, Sharma VK. Retrospective and prospective study of ovarian tumors and tumor-like lesions. Indian J PatholMicrobiol 2007;50(3):525-7

8.Okugawa K, Hirakawa T, Fukushima K, Kamura T, Amada S, Nakano H. Relation between age, histological type and size of ovarian tumors. Int J GynecolObstet 2001;74(1):4550.

9. Bhattacharya MM, Shinde SD, Purandare VN. A clinicopathological analysis of 270 ovarian tumors. J Postgrad Med 1980;26(2):103-7.

10. Sarwar CM, Siddiqui N, Khokhar RA, Badar F. Epithelial ovarian cancer at a cancer hospital in a developing country. Asian Pac J Cancer Prev 2006;7(4):595-8.

11.S.Maharjan,clinicomorphological study of ovarian lesions;journal of chitwan medical college 2013;3(6):17-24

12. Vaidya S, Sharma P, KC S, Vaidya SA. Spectrum of ovarian tumors in a referral hospital in Nepal.Journal of Pathology of Nepal 2014; 4: 539 -543.13.Kayastha S. Study of ovarian tumors in Nepal Medical College Teaching Hospital. Nepal Med Coll J 2009;1 (3):200-2.

14.Yasmin S, Yasmin A, Asif M. Clinicohistological pattern of ovarian tumours in Peshawar region. J Ayub Med Coll Abbottabad 2008; 20: 11-13.

15. Khan AA, Luqman M, Jamal S, Mamoon N, Mushtaq S. Clinicopathologicalanalysis of ovarian tumors. Pak J Pathol 2005;16(1):28-32

16.Jha R, Karki S. Histological pattern of ovarian tumors and their age distribution. Nepal Med Coll J 2008;10(2):81-5.

17. Seidman JD, Kurman RJ, Ronnett BM. Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis. Am J SurgPathol.In press 2003.

18.Soslow RA. Histologic Subtypes of Ovarian Carcinoma: An Overview. International Journal of Gynecological Pathology2008;27:161–74

19. Hallgrimsson J, Scully RE. borderline and malignant Brenner tumours of the ovary. A report of 15 cases.ActaPathol Microbial Scand. 1972;233:56-6.

20.Scully RE, Young RH, Clement PB. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament, 3rd series, no.23. Washington, DC: Armed Forces Institute of Pathology,1998. pp153-4.

21.Kayastha S. Study of ovarian tumors in Nepal Medical College Teaching Hospital. Nepal Med Coll J 2009;1 (3):200-2.

Downloads

Additional Files

Published

28-01-2018

How to Cite

1.
Chelladurai V, Chander V, Srinivasan C. Retrospective study of spectrum of ovarian tumours in a tertiary care setup. Ann of Pathol and Lab Med [Internet]. 2018 Jan. 28 [cited 2024 Dec. 26];5(1):A75-81. Available from: https://pacificejournals.com/journal/index.php/apalm/article/view/apalm1672

Issue

Section

Original Article